360 related articles for article (PubMed ID: 24176032)
1. Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia.
Chkhartishvili N; Kempker RR; Dvali N; Abashidze L; Sharavdze L; Gabunia P; Blumberg HM; Del Rio C; Tsertsvadze T
BMC Infect Dis; 2013 Nov; 13():513. PubMed ID: 24176032
[TBL] [Abstract][Full Text] [Related]
2. Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.
O'Shea MK; Fletcher TE; Beeching NJ; Dedicoat M; Spence D; McShane H; Cunningham AF; Wilson D
PLoS One; 2014; 9(5):e97366. PubMed ID: 24816576
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
4. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
[TBL] [Abstract][Full Text] [Related]
5. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
[TBL] [Abstract][Full Text] [Related]
6. Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test.
Ramos JM; Robledano C; Masiá M; Belda S; Padilla S; Rodríguez JC; Gutierrez F
BMC Infect Dis; 2012 Jul; 12():169. PubMed ID: 22849726
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of Tuberculin Skin Test (TST) and T-SPOT.TB Tests for Diagnosis of Latent Tuberculosis Infection (LTBI) in HIV-infected Patients].
Binay UD; Fincancı M; Fersan E; Karakeçili F
Mikrobiyol Bul; 2019 Oct; 53(4):388-400. PubMed ID: 31709936
[TBL] [Abstract][Full Text] [Related]
8. Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting.
Chandrasekaran P; Mave V; Thiruvengadam K; Gupte N; Shivakumar SVBY; Hanna LE; Kulkarni V; Kadam D; Dhanasekaran K; Paradkar M; Thomas B; Kohli R; Dolla C; Bharadwaj R; Sivaramakrishnan GN; Pradhan N; Gupte A; Murali L; Valvi C; Swaminathan S; Gupta A;
PLoS One; 2018; 13(8):e0199360. PubMed ID: 30067752
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and incidence of latent tuberculosis infection in georgian healthcare workers.
Whitaker JA; Mirtskhulava V; Kipiani M; Harris DA; Tabagari N; Kempker RR; Blumberg HM
PLoS One; 2013; 8(3):e58202. PubMed ID: 23536789
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
Doan TN; Eisen DP; Rose MT; Slack A; Stearnes G; McBryde ES
PLoS One; 2017; 12(11):e0188631. PubMed ID: 29182688
[TBL] [Abstract][Full Text] [Related]
11. The Clinical Usefulness of Tuberculin Skin Test versus Interferon-Gamma Release Assays for Diagnosis of Latent Tuberculosis in HIV Patients: A Meta-Analysis.
Ayubi E; Doosti-Irani A; Sanjari Moghaddam A; Sani M; Nazarzadeh M; Mostafavi E
PLoS One; 2016; 11(9):e0161983. PubMed ID: 27622293
[TBL] [Abstract][Full Text] [Related]
12. Poor agreement between diagnostic tests for latent tuberculosis infection among HIV-infected persons in Hong Kong.
Leung CC; Chan K; Yam WC; Lee MP; Chan CK; Wong KH; Ho PL; Mak I; Tam CM
Respirology; 2016 Oct; 21(7):1322-9. PubMed ID: 27121551
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy.
Vassilopoulos D; Tsikrika S; Hatzara C; Podia V; Kandili A; Stamoulis N; Hadziyannis E
Clin Vaccine Immunol; 2011 Dec; 18(12):2102-8. PubMed ID: 21994356
[TBL] [Abstract][Full Text] [Related]
14. Predictors of discordant tuberculin skin test and QuantiFERON®-TB Gold In-Tube results in various high-risk groups.
Weinfurter P; Blumberg HM; Goldbaum G; Royce R; Pang J; Tapia J; Bethel J; Mazurek GH; Toney S; Albalak R;
Int J Tuberc Lung Dis; 2011 Aug; 15(8):1056-61. PubMed ID: 21740668
[TBL] [Abstract][Full Text] [Related]
15. QuantiFERON conversion following tuberculin administration is common in HIV infection and relates to baseline response.
Esmail H; Thienemann F; Oni T; Goliath R; Wilkinson KA; Wilkinson RJ
BMC Infect Dis; 2016 Oct; 16(1):545. PubMed ID: 27717329
[TBL] [Abstract][Full Text] [Related]
16. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain.
Calzada-Hernández J; Anton J; Martín de Carpi J; López-Montesinos B; Calvo I; Donat E; Núñez E; Blasco Alonso J; Mellado MJ; Baquero-Artigao F; Leis R; Vegas-Álvarez AM; Medrano San Ildefonso M; Pinedo-Gago MDC; Eizaguirre FJ; Tagarro A; Camacho-Lovillo M; Pérez-Gorricho B; Gavilán-Martín C; Guillén S; Sevilla-Pérez B; Peña-Quintana L; Mesa-Del-Castillo P; Fortuny C; Tebruegge M; Noguera-Julian A
Eur J Pediatr; 2023 Jan; 182(1):307-317. PubMed ID: 36335186
[TBL] [Abstract][Full Text] [Related]
17. IFN-γ response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection.
Latorre I; Martínez-Lacasa X; Font R; Lacoma A; Puig J; Tural C; Lite J; Prat C; Cuchi E; Ausina V; Domínguez J
BMC Infect Dis; 2010 Dec; 10():348. PubMed ID: 21143955
[TBL] [Abstract][Full Text] [Related]
18. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis.
Auguste P; Tsertsvadze A; Pink J; Court R; McCarthy N; Sutcliffe P; Clarke A
BMC Infect Dis; 2017 Mar; 17(1):200. PubMed ID: 28274215
[TBL] [Abstract][Full Text] [Related]
19. Poor concordance between interferon-gamma release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals.
Talati NJ; Seybold U; Humphrey B; Aina A; Tapia J; Weinfurter P; Albalak R; Blumberg HM
BMC Infect Dis; 2009 Feb; 9():15. PubMed ID: 19208218
[TBL] [Abstract][Full Text] [Related]
20. A toolbox for tuberculosis (TB) diagnosis: an Indian multicentric study (2006-2008). Evaluation of QuantiFERON-TB gold in tube for TB diagnosis.
Lagrange PH; Thangaraj SK; Dayal R; Deshpande A; Ganguly NK; Girardi E; Joshi B; Katoch K; Katoch VM; Kumar M; Lakshmi V; Leportier M; Longuet C; Malladi SV; Mukerjee D; Nair D; Raja A; Raman B; Rodrigues C; Sharma P; Singh A; Singh S; Sodha A; Kabeer BS; Vernet G; Goletti D
PLoS One; 2013; 8(9):e73579. PubMed ID: 24039990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
